Pulmonary Hypertension in Latin America
Part of the Latin America Task Force new webinar series, this session aims to evaluate PH and differential diagnosis, and the differences in phenotype presentations in Latin America and USA / Europe. Our webinars are free and open to all.
PAH is classically described as a disease in young adults, with no comorbidities. However, recent registries showed the epidemiology has changed to older patients with comorbidities (obesity, diabetes, hypertension, and coronary heart disease). In contrast, in Latin America, registries have shown that PAH patients are younger and have fewer comorbidities, which raises the question of whether Latin American patients present with a different phenotype.
28 October 2025, 15:00 GMT
- PH – diagnostic evaluation
- PH phenotypes and patient presentation - differences in Latin America vs. USA / Europe Tomas Pulido, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico
- Treatment of PAH - Latin America vs. USA / Europe. Medications vs. Septostomy; regional variations Nayeli Zayas, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico and Rogeiro de Souza, University of São Paulo, Brazil
- PH registry updates Mauricio Orozco-Levi, Hospital Internacional de Colombia and Adrian Lescano, Fundación Favaloro, Argentina
Moderated by Vinicio de Jesus Perez, Stanford School of Medicine, USA